The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
Recruiting · NCT06765850 · Observational (researchers observe without assigning treatment) · Lead sponsor: Technische Universität Dresden
View the official record on ClinicalTrials.gov →What this trial is about
Prospective, single-centre study with the central question of how the metabolome from blood samples, different body fluids and tissues between patients patients with malignant melanoma in different tumour tumour stages and healthy patients and whether this is suitable for early detection of initial diagnosis, recurrence or stage shift at an early stage. The biosamples are collected in the BioBank Dresden and used for the NMR and LC-MS analyses described here. It is planned to use the biosamples for further analyses.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Current or past history of melanoma
- Ongoing therapy or tumour aftercare at the Skin Cancer Centre at Dresden University Hospital
Exclusion criteria
- Refusal to participate in the study
- Lack of capacity to consent
Where it is running
1 location listed.
- University Hospital Carl Gustav Carus - Dresden, Saxony, Germany